Literature DB >> 11145833

Faecal excretion profile of moxidectin and ivermectin after oral administration in horses.

R Pérez1, I Cabezas, J F Sutra, P Galtier, M Alvinerie.   

Abstract

A study was undertaken to evaluate and compare faecal excretion of moxidectin and ivermectin in horses after oral administration of commercially available preparations. Ten clinically healthy adult horses, weighing 390-446 kg body weight (b.w.), were allocated to two experimental groups. Group I was treated with an oral gel formulation of moxidectin at the manufacturer's recommended therapeutic dose of 0.4 mg/kg b.w. Group II was treated with an oral paste formulation of ivermectin at the recommended dose of 0.2 mg/kg b.w. Faecal samples were collected at different times between 1 and 75 days post-treatment. After faecal drug extraction and derivatization, samples were analysed by High Performance Liquid Chromatography using fluorescence detection and computerized kinetic analysis. For both drugs the maximum concentration level was reached at 2.5 days post administration. The ivermectin treatment groups' faecal concentrations remained above the detectable level for 40 days (0.6 +/- 0.3 ng/g), whereas the moxidectin treatment group remained above the detectable level for 75 days (4.3 +/- 2.8 ng/g). Ivermectin presented a faster elimination rate than moxidectin, reaching 90% of the total drug excreted in faeces at four days post-treatment, whereas moxidectin reached similar levels at eight days post-treatment. No significant differences were observed for the values of maximum faecal concentration (C(max)) and time of C(max)(T(max)) between both groups of horses, demonstrating similar patterns of drug transference from plasma to the gastrointestinal tract. The values of the area under the faecal concentration time curve were slightly higher in the moxidectin treatment group (7104 +/- 2277 ng.day/g) but were not significantly different from those obtained in the ivermectin treatment group (5642 +/- 1122 ng.day/g). The results demonstrate that although a 100% higher dose level of moxidectin was used, attaining higher plasma concentration levels and more prolonged excretion and gut secretion than ivermectin, the concentration in faeces only represented 44.3+/- 18.0% of the total parental drug administered compared to 74.3 +/- 20.2% for ivermectin. This suggests a higher level of metabolization for moxidectin in the horse. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11145833     DOI: 10.1053/tvjl.2000.0521

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  4 in total

1.  Semifield assessment of the runoff potential and environmental risk of the parasiticide drug ivermectin under Mediterranean conditions.

Authors:  Carlos Fernández; Miguel Angel Porcel; Alvaro Alonso; Manuel San Andrés; José Vicente Tarazona
Journal:  Environ Sci Pollut Res Int       Date:  2011-03-04       Impact factor: 4.223

Review 2.  Toxicology of avermectins and milbemycins (macrocylic lactones) and the role of P-glycoprotein in dogs and cats.

Authors:  Valentina M Merola; Paul A Eubig
Journal:  Vet Clin North Am Small Anim Pract       Date:  2012-03       Impact factor: 2.093

3.  The Anthelmintic Ingredient Moxidectin Negatively Affects Seed Germination of Three Temperate Grassland Species.

Authors:  Carsten Eichberg; Manuel Wohde; Kerstin Müller; Anja Rausch; Christina Scherrmann; Theresa Scheuren; Rolf-Alexander Düring; Tobias W Donath
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

4.  Comment on: "The treatment of sarcoptic mange in wildlife: a systematic review".

Authors:  Barbara Moroni; Marta Valldeperes; Emmanuel Serrano; Jorge Ramón López-Olvera; Santiago Lavín; Luca Rossi
Journal:  Parasit Vectors       Date:  2020-09-15       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.